Decibel Therapeutics (DBTX) Financials

$4.91

$0.00 (0.00%)

As on 04-Oct-2023 09:30EDT

Market cap

$123 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	66.00	63.96	50.23	39.56	44.08	37.86
Operating Profit (EBIT)	-66.00	-63.96	-50.23	-39.56	-44.08	-37.86
Other Income	2.23	1.19	--	--	--	--
Profit before Tax	-63.11	-62.77	-50.03	-39.34	-42.67	-36.16
Provision for Tax	0.28	0.24	1.80	-1.70	-1.41	1.70
Profit after Tax (Net Income)	-63.39	-63.01	-51.82	-37.64	-41.26	-36.16
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-47.45	-63.01	-54.13	7.08	-53.70	-45.44

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	53.31	81.79	141.69	-162.69	15.85	57.45
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	14.50	19.14	22.25	9.60	17.54	24.84
Current Liabilities	26.58	22.44	20.54	19.37	9.45	11.00
Total Liabilities	120.97	123.37	184.48	67.29	42.84	93.29

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	13.94	15.34	20.29	9.46	9.26	9.68
Current Assets	80.45	108.03	164.19	57.83	33.57	83.61
Total Assets	120.97	123.37	184.48	67.29	42.84	93.29
Total Debt*	12.85	14.05	0.21	0.19	--	--
Net Current Assets	53.87	85.59	143.65	38.45	24.12	72.61

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-56.90	-43.15	-32.66	-49.41	-36.08
Cash Flow from Investing Activities	--	55.10	-101.00	-13.01	57.34	-71.39
Cash from Financing Activities	--	-0.21	152.51	54.85	-0.01	55.06
Net Cash Inflow / Outflow	--	-2.01	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-2.54	-2.52	-2.08	-3.11	-5.61	--
Cash EPS ($)	--	-2.47	-2.03	-2.97	-5.37	--
Adjusted Book Value ($)	--	3.28	5.70	--	2.15	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.28	-1.73	-2.70	-6.72	--
Free Cash Flow per Share ($)	--	-2.30	-1.76	-2.72	-6.81	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-53.00	503.28	51.33	-112.59	--
ROE (%)	-93.84	-56.38	493.55	51.27	-112.59	--
ROA (%)	-41.97	-40.93	-41.17	-68.36	-60.63	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-2,845.24	-5,285.65	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-12.39	-27.33	-26.96	10.25	-16.44	--
Net Profit Growth (%)	-5.02	-21.58	-37.68	8.78	-14.10	--
EPS Growth (%)	-4.74	-0.21	0.33	0.45	--	--
Book Value Growth (%)	-52.45	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.81	-2.23	--	--	--
Price / Book Value	0.67	0.63	0.82	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.55	0.63	0.67	--	--	--
Close Price ($)	3.85	2.05	4.65	--	--	--
High Price ($)	5.78	5.78	24.39	--	--	--
Low Price ($)	1.61	1.61	4.49	--	--	--
Market Cap ($ Cr)	123.37	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.17	0.00	0.00	--	--
Short term debt to equity ratio	0.07	0.04	0.00	0.00	--	--
Current Ratio	3.03	4.81	7.99	2.98	3.55	7.60
Quick Ratio	3.03	--	13.46	--	--	--
Interest Coverage	-34.26	-53.66	-245.03	-719.33	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.